Training for success
New biopharmaceutical sciences masterâs program launches with industry support
Fueled by generous philanthropic support and insights from industry partners, the University of Delaware launched a new masterâs program in biopharmaceutical sciences in June.
AstraZeneca, Bristol Myers Squibb and Merck & Co. contributed leadership support to lay the foundation for the program and will provide the first cohort of students with funding, extended internships and mentorship. In addition to the philanthropic gifts which will help create equity and access for students of underrepresented groups, executives from the companies helped shape the vision and program experience. Their input and expertise ensure students are gaining valuable knowledge and experiences that will enable them to contribute more quickly and meaningfully once they join the industry workforce after graduation.